|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/475 | |
| A61K 9/127 | |||
| A61P 35/02 | |||
| A61K 9/00 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3324969 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16828625.0 |
| Europos patento paraiškos padavimo data | 2016-07-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/043622 |
| Data | 2016-07-22 |
| (87) | Numeris | WO 2017/015584 |
| Data | 2017-01-26 |
| (30) | Numeris | Data | Šalis |
| 201562195711 P | 2015-07-22 | US |
| (72) |
MONTE, William, T., US
ABRA, Robert, Malcolm, US
LUO,Bing, US
ZHANG, Yuanpeng, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
11500 South Eastern Avenue Suite 240, Henderson, NV 89052,
US
|
| (54) | A READY-TO-USE FORMULATION FOR VINCRISTINE SULFATE LIPOSOME INJECTION |
| A READY-TO-USE FORMULATION FOR VINCRISTINE SULFATE LIPOSOME INJECTION |